Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on VCYT: Veracyte price target raised to $44 from $40 at Scotiabank Veracyte price target raised to $46 from $43 at UBS Veracyte Inc. Reports Strong Q3 2024 Growth Veracyte reports Q3 adjusted EPS 33c, consensus 3c Veracyte raises FY24 revenue view to $442M-$445M from $432M-$438M